Halozyme Therapeutics Inc (NASDAQ:HALO)

During the Trading Day
22.78 +0.68 / +3.08%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
22.99 +0.21 / +0.92%
Volume: 30.5K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year




Operating ActivitiesNet Income / Starting Line-19.8M-53.6M-83.5M-68.4M
Total Other Cash Flow5.6M8.4M10.8M19.0M
Funds From Operations-13.1M-44.1M-71.4M-47.6M
Funds From/For Other Operating Expenses21.2M20.2M-22.2M-106.0K
Net Cash Flow - Operating Activities-34.4M-64.3M-49.2M-47.5M
InvestingIncrease In Investments0.000.00-48.9M-88.9M
Decrease In Investments0.000.003.4M57.3M
Capital Expenditures-828.5K-1.4M-2.3M-1.4M
Net Cash Flow Investing-828.5K-1.4M-47.9M-33.0M
FinancingShort Term Borrowings0.
Long Term Borrowings0.0029.7M20.0M0.00
Long Term Debt Reduction0.
Net Proceeds Stock Sale4.7M83.2M5.1M114.5M
Common Preferred Redeemed0.
Common Dividends0.
Cash Dividends Paid - Total0.
Other Sources - Financing0.
Other Uses - Financing0.
Net Cash Flow - Financing4.7M112.8M25.1M114.5M
Exchange RateEffect of Exchange Rate on Cash--
Net Change In Cash-30.4M47.1M-72.0M34.0M

To view my watchlist

Not a member yet?

Sign up now for a free account